| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2023 | JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH | LEONHARDSTRASSE 59 | GRAZ | | | | AUT | U01FD007669 | Optimized clinical dermal Open Flow Microperfusion study design to demonstrate bioequivalence based on cutaneous pharmacokinetics | 000 | 2 | FDA | 10/23/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2023 | JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH | LEONHARDSTRASSE 59 | GRAZ | | | | AUT | U01FD007669 | Optimized clinical dermal Open Flow Microperfusion study design to demonstrate bioequivalence based on cutaneous pharmacokinetics | 000 | 2 | FDA | 5/28/2024 | $0 |
| | 2024 | 2023 | JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH | LEONHARDSTRASSE 59 | GRAZ | | | | AUT | U01FD007669 | Optimized clinical dermal Open Flow Microperfusion study design to demonstrate bioequivalence based on cutaneous pharmacokinetics | 001 | 2 | FDA | 9/23/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $500,000 ) |
| | 2023 | 2023 | JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH | LEONHARDSTRASSE 59 | GRAZ | STEIERMARK | | | AUT | U01FD007669 | Optimized clinical dermal Open Flow Microperfusion study design to demonstrate bioequivalence based on cutaneous pharmacokinetics | 000 | 2 | FDA | 8/1/2023 | $500,000 |
| | 2023 | 2023 | JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH | LEONHARDSTRASSE 59 | GRAZ | STEIERMARK | | | AUT | U01FD007669 | Optimized clinical dermal Open Flow Microperfusion study design to demonstrate bioequivalence based on cutaneous pharmacokinetics | 001 | 2 | FDA | 8/15/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $250,000 ) |
| | 2022 | 2022 | JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH | LEONHARDSTRASSE 59 | GRAZ | STEIERMARK | | | AUT | U01FD007669 | Optimized clinical dermal Open Flow Microperfusion study design to demonstrate bioequivalence based on cutaneous pharmacokinetics | 000 | 1 | FDA | 9/12/2022 | $250,000 |
| | 2022 | 2018 | JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH | LEONHARDSTRASSE 59 | GRAZ | STEIERMARK | | | AUT | U01FD005861 | Development of a Universal Bioequivalence Test Method for Topical Drugs using dOFM | 000 | 3 | FDA | 6/16/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2018 | JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH | LEONHARDSTRASSE 59 | GRAZ | STEIERMARK | | | AUT | U01FD005861 | Development of a Universal Bioequivalence Test Method for Topical Drugs using dOFM | 000 | 3 | FDA | 2/17/2021 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $0 ) |
| | 2019 | 2018 | JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH | LEONHARDSTRASSE 59 | GRAZ | STEIERMARK | 8010 | | AUT | U01FD005861 | Development of a Universal Bioequivalence Test Method for Topical Drugs using dOFM | 001 | 3 | FDA | 8/9/2019 | $0 |
| | 2019 | 2018 | JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH | LEONHARDSTRASSE 59 | GRAZ | STEIERMARK | 8010 | | AUT | U01FD005861 | Development of a Universal Bioequivalence Test Method for Topical Drugs using dOFM | 000 | 3 | FDA | 10/23/2018 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $1,000,000 ) |
| | 2018 | 2018 | JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH | LEONHARDSTRASSE 59 | GRAZ | STEIERMARK | 8010 | | AUT | U01FD005861 | Development of a Universal Bioequivalence Test Method for Topical Drugs using dOFM | 001 | 3 | FDA | 8/16/2018 | $1,000,000 |
| | 2018 | 2017 | JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH | LEONHARDSTRASSE 59 | GRAZ | STEIERMARK | 8010 | | AUT | U01FD005861 | Development of a Universal Bioequivalence Test Method for Topical Drugs using dOFM | 000 | 2 | FDA | 12/5/2017 | $0 |
| | 2018 | 2014 | JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH | LEONHARDSTRASSE 59 | GRAZ | STEIERMARK | 8010 | | AUT | U01FD004946 | NOVEL METHODOLOGIES AND IVIVC APPROACHES TO ASSESS BIOEQUIVALENCE OF TOPICAL DRUG | 000 | 2 | FDA | 12/5/2017 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $500,000 ) |
| | 2017 | 2017 | JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH | LEONHARDSTRASSE 59 | GRAZ | STEIERMARK | 8010 | | AUT | U01FD005861 | Development of a Universal Bioequivalence Test Method for Topical Drugs using dOFM | 000 | 2 | FDA | 8/24/2017 | $500,000 |
|
| Issue Date FY: 2016 ( Subtotal = $500,000 ) |
| | 2016 | 2016 | Joanneum Research | Elisabethstrasse 5 | Graz | | | | AUT | U01FD005861 | Development of a Universal Bioequivalence Test Method for Topical Drugs using dOFM | 000 | 1 | FDA | 9/14/2016 | $500,000 |
|
| Issue Date FY: 2014 ( Subtotal = $250,000 ) |
| | 2014 | 2014 | Joanneum Research | Elisabethstrasse 5 | Graz | | | | AUT | U01FD004946 | NOVEL METHODOLOGIES AND IVIVC APPROACHES TO ASSESS BIOEQUIVALENCE OF TOPICAL DRUG | 001 | 2 | FDA | 9/9/2014 | $250,000 |
|
|
